Venkatasamy, A.; Guerin, E.; Blanchet, A.; Orvain, C.; Devignot, V.; Jung, M.; Jung, A.C.; Chenard, M.-P.; Romain, B.; Gaiddon, C.;
et al. Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer. Pharmaceutics 2021, 13, 1485.
https://doi.org/10.3390/pharmaceutics13091485
AMA Style
Venkatasamy A, Guerin E, Blanchet A, Orvain C, Devignot V, Jung M, Jung AC, Chenard M-P, Romain B, Gaiddon C,
et al. Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer. Pharmaceutics. 2021; 13(9):1485.
https://doi.org/10.3390/pharmaceutics13091485
Chicago/Turabian Style
Venkatasamy, Aina, Eric Guerin, Anais Blanchet, Christophe Orvain, Véronique Devignot, Matthieu Jung, Alain C. Jung, Marie-Pierre Chenard, Benoit Romain, Christian Gaiddon,
and et al. 2021. "Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer" Pharmaceutics 13, no. 9: 1485.
https://doi.org/10.3390/pharmaceutics13091485
APA Style
Venkatasamy, A., Guerin, E., Blanchet, A., Orvain, C., Devignot, V., Jung, M., Jung, A. C., Chenard, M.-P., Romain, B., Gaiddon, C., & Mellitzer, G.
(2021). Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer. Pharmaceutics, 13(9), 1485.
https://doi.org/10.3390/pharmaceutics13091485